STAGNO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 849
EU - Europa 419
AS - Asia 309
SA - Sud America 128
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.815
Nazione #
US - Stati Uniti d'America 832
IT - Italia 201
SG - Singapore 171
BR - Brasile 120
IE - Irlanda 90
CN - Cina 84
CI - Costa d'Avorio 75
DE - Germania 35
SN - Senegal 27
UA - Ucraina 22
RU - Federazione Russa 18
VN - Vietnam 18
CA - Canada 15
SE - Svezia 9
GB - Regno Unito 8
TR - Turchia 7
CZ - Repubblica Ceca 6
FI - Finlandia 6
UZ - Uzbekistan 5
FR - Francia 4
NL - Olanda 4
AT - Austria 3
BE - Belgio 3
IN - India 3
IQ - Iraq 3
LB - Libano 3
MA - Marocco 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
EC - Ecuador 2
GR - Grecia 2
HK - Hong Kong 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PL - Polonia 2
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MX - Messico 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 1.815
Città #
Santa Clara 195
Chandler 169
Singapore 107
Chicago 99
Dublin 90
Abidjan 75
Catania 41
Civitanova Marche 33
Boardman 32
Ashburn 28
Dakar 27
Cambridge 23
Lawrence 23
Andover 22
Houston 22
Jacksonville 18
Dong Ket 14
Des Moines 13
Grafing 13
Munich 12
Nanjing 12
São Paulo 12
Wilmington 12
Palermo 10
Los Angeles 8
Milan 8
Ottawa 7
Beijing 6
Hanover 6
Saint Petersburg 6
Belo Horizonte 5
Council Bluffs 5
Falls Church 5
Giardini-Naxos 5
Helsinki 5
Jiaxing 5
Rome 5
Toronto 5
Bari 4
Brno 4
Hanoi 4
Hebei 4
Jinan 4
Nanchang 4
New York 4
Santa Venerina 4
The Dalles 4
Belém 3
Bremen 3
Brooklyn 3
Brussels 3
Florence 3
Juiz de Fora 3
Seattle 3
Tremestieri Etneo 3
Zhengzhou 3
Abuja 2
Aci Catena 2
Amman 2
Assago 2
Asunción 2
Bauru 2
Bergamo 2
Campinas 2
Canoinhas 2
Casablanca 2
Comiso 2
Cotia 2
Curitiba 2
Dubai 2
Fremont 2
Guarulhos 2
Istanbul 2
Messina 2
Montreal 2
Nairobi 2
Newham 2
Osasco 2
Pace del Mela 2
Porto Seguro 2
Pune 2
Redwood City 2
Rio de Janeiro 2
San Giovanni la Punta 2
San Mateo 2
Sant'Agata di Militello 2
Shenyang 2
Siracusa 2
Valparaíso de Goiás 2
Washington 2
Ahmetli 1
Alfenas 1
Almaty 1
Ancona 1
Araras 1
Athens 1
Atibaia 1
Augusta 1
Aurora do Pará 1
Baghdad 1
Totale 1.324
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 151
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 91
In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside 90
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 87
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 84
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 82
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 80
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 78
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 78
Uncommon long-term survival in a patient with chronic myeloid leukemia 77
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 77
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 76
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 76
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 71
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 71
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 69
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 67
Evaluation of taxol cytotoxicity on B-CLL cells in vitro 64
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 62
Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN-treated chronic myeloid leukemia (CML) patients 56
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 56
Differences among young adults, adults and elderly chronic myeloid leukemia patients 54
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper 50
A case of high-risk AML in a patient with advanced systemic mastocytosis 44
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 42
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 37
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions 20
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 1
Totale 1.891
Categoria #
all - tutte 7.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 0 0 0 0 0 9 22
2020/2021112 8 4 5 11 29 7 8 1 17 1 5 16
2021/2022164 4 24 3 3 34 5 27 4 9 1 9 41
2022/2023432 28 48 16 50 31 64 1 80 85 5 18 6
2023/2024251 13 40 8 12 8 66 1 15 5 10 50 23
2024/2025767 12 147 37 83 171 115 77 36 34 52 3 0
Totale 1.891